HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wiesel, F.-A. Articles by Hagenfeldt, L. Search for Related Content PubMed PubMed Citation Articles by Wiesel, F.-A. Articles by Hagenfeldt, L.

The Transport of Tyrosine into the Human Brain as Determined with L-[1-¹¹C]Tyrosine and PET

Department of Psychiatry, University of Uppsala, Sweden
Departments of Clinical Neurophysiology Psychiatry and Psychology, and Clinical Chemistry, Karolinska Institute, Stockholm, Sweden

Correspondence: For reprints contact: Frits-Axel Wiesel, MD, PhD, Department of Psychiatry, Uppsala University, Ulleråaker, S-750 17 Uppsala, Sweden.

ABSTRACT

An alteration of dopaminergic transmission in the brain has been proposed for schizophrenia. To explore this, the rate constant for the intransport of L-tyrosine across the blood-brain barrier in healthy controls and in patients with schizophrenia (DSM-III-R) was determined with PET and L-[1-¹¹C] tyrosine as the tracer. Kinetics for tyrosine transport were determined according to a two-compartment model using radioactivity data of arterial blood and brain tissue sampled between 1 and 3.5 min after a bolus injection of L-[1-¹¹C] tyrosine. Radioactivity was measured every second in the blood and in 10-sec intervals in the brain tissue. In the normal controls the brain intransport rate constant for tyrosine was 0.052 ml/g/min with an influx rate of 2.97 nmol/g/min. The patients had a similar intransport rate constant (0.045 ml/g/min) but a lower influx rate of tyrosine 1.95 nmol/g/min (p < 0.05). The patients' tyrosine concentrations in the blood were lower. For data sampled between 5 and 25 min, the net accumulation rate of tyrosine into the brain was 0.015 ml/g/min in the controls which did not differ to the patients' rate. However, the net utilization of tyrosine was lower in the patients (0.672 nmol/g/min) than in the controls (0.883 nmol/g/min) despite similar tissue concentrations of tyrosine.

This article has been cited by other articles:

				V. Josserand, H. Pelerin, B. de Bruin, B. Jego, B. Kuhnast, F. Hinnen, F. Duconge, R. Boisgard, F. Beuvon, F. Chassoux, et al. Evaluation of Drug Penetration into the Brain: A Double Study by in Vivo Imaging with Positron Emission Tomography and Using an in Vitro Model of the Human Blood-Brain Barrier J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 79 - 86. [Abstract] [Full Text] [PDF]

				G. Westera and P. A. Schubiger Functional Imaging of Physiological Processes by Positron Emission Tomography Physiology, August 1, 2003; 18(4): 175 - 178. [Abstract] [Full Text] [PDF]

				L. Flyckt, N. Venizelos, G. Edman, L. Bjerkenstedt, L. Hagenfeldt, and F.-A. Wiesel Aberrant Tyrosine Transport Across the Cell Membrane in Patients With Schizophrenia Arch Gen Psychiatry, October 1, 2001; 58(10): 953 - 958. [Abstract] [Full Text] [PDF]